TAF II p18, also known as TATA-binding protein-associated factor 18, is a protein that plays a critical role in transcriptional regulation. It is part of the TFIID complex, which is involved in the initiation of transcription by RNA polymerase II. TAF II p18 is specifically associated with the TFIID subcomplex known as the TAF1B module. This module contributes to the formation of the preinitiation complex and the recruitment of RNA polymerase II to the promoter region of genes. TAF II p18's involvement in these processes makes it a crucial factor in controlling gene expression.
TAF II p18 inhibitors are compounds that target the activity of TAF II p18, often with the aim of modulating gene transcription. While specific small molecule inhibitors directly targeting TAF II p18 may not be widely reported, the modulation of TAF II p18-related signaling can potentially be achieved through various approaches. These may include compounds that affect the assembly of the TFIID complex, alter the interaction between TAF II p18 and other components of the transcription machinery, or disrupt the binding of TAF II p18 to DNA. The development of TAF II p18 inhibitors could hold promise for understanding gene regulation mechanisms and potentially influencing cellular processes that rely on accurate transcriptional control.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin has been reported to inhibit the binding of TAF II p18 to DNA. It can interfere with the transcriptional activity of TAF II p18 and its interactions with other transcriptional components. | ||||||